349 related articles for article (PubMed ID: 25867461)
1. Decreased concentration of Klotho in the cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.
Emami Aleagha MS; Siroos B; Ahmadi M; Balood M; Palangi A; Haghighi AN; Harirchian MH
J Neuroimmunol; 2015 Apr; 281():5-8. PubMed ID: 25867461
[TBL] [Abstract][Full Text] [Related]
2. Tau protein in cerebrospinal fluid: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis.
Martínez-Yélamos A; Saiz A; Bas J; Hernandez JJ; Graus F; Arbizu T
Neurosci Lett; 2004 Jun; 363(1):14-7. PubMed ID: 15157986
[TBL] [Abstract][Full Text] [Related]
3. Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
Teunissen CE; Sombekke M; van Winsen L; Killestein J; Barkhof F; Polman CH; Dijkstra CD; Blankenstein MA; Pratico D
Mult Scler; 2012 Aug; 18(8):1092-8. PubMed ID: 22695538
[TBL] [Abstract][Full Text] [Related]
4. Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome.
Sladkova V; Mareš J; Lubenova B; Zapletalova J; Stejskal D; Hlustik P; Kanovsky P
Neurol Res; 2011 May; 33(4):415-20. PubMed ID: 21535941
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
[TBL] [Abstract][Full Text] [Related]
6. Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosis.
Beyer NH; Lueking A; Kowald A; Frederiksen JL; Heegaard NH
J Neuroimmunol; 2012 Jan; 242(1-2):26-32. PubMed ID: 22177943
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis influences on the augmentation of serum Klotho concentration.
Ahmadi M; Emami Aleagha MS; Harirchian MH; Yarani R; Tavakoli F; Siroos B
J Neurol Sci; 2016 Mar; 362():69-72. PubMed ID: 26944121
[TBL] [Abstract][Full Text] [Related]
8. Elevated CSF concentration of CCL3 and CCL4 in relapsing remitting multiple sclerosis patients.
Soleimani M; Soleymani A; Seyyedirad N
J Immunoassay Immunochem; 2019; 40(4):378-385. PubMed ID: 31268406
[TBL] [Abstract][Full Text] [Related]
9. Klotho gene expression decreases in peripheral blood mononuclear cells (PBMCs) of patients with relapsing-remitting multiple sclerosis.
Karami M; Mehrabi F; Allameh A; Pahlevan Kakhki M; Amiri M; Emami Aleagha MS
J Neurol Sci; 2017 Oct; 381():305-307. PubMed ID: 28991703
[TBL] [Abstract][Full Text] [Related]
10. Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis.
Martínez MA; Olsson B; Bau L; Matas E; Cobo Calvo Á; Andreasson U; Blennow K; Romero-Pinel L; Martínez-Yélamos S; Zetterberg H
Mult Scler; 2015 Apr; 21(5):550-61. PubMed ID: 25732842
[TBL] [Abstract][Full Text] [Related]
11. Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
Komori M; Matsuyama Y; Nirasawa T; Thiele H; Becker M; Alexandrov T; Saida T; Tanaka M; Matsuo H; Tomimoto H; Takahashi R; Tashiro K; Ikegawa M; Kondo T
Ann Neurol; 2012 May; 71(5):614-23. PubMed ID: 22522477
[TBL] [Abstract][Full Text] [Related]
12. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.
Ge Y; Grossman RI; Udupa JK; Wei L; Mannon LJ; Polansky M; Kolson DL
Radiology; 2000 Mar; 214(3):665-70. PubMed ID: 10715027
[TBL] [Abstract][Full Text] [Related]
13. CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.
Romme Christensen J; Börnsen L; Khademi M; Olsson T; Jensen PE; Sørensen PS; Sellebjerg F
Mult Scler; 2013 Jun; 19(7):877-84. PubMed ID: 23178691
[TBL] [Abstract][Full Text] [Related]
14. Expression of leukemia inhibitory factor in the cerebrospinal fluid of patients with multiple sclerosis.
Mashayekhi F; Salehi Z
J Clin Neurosci; 2011 Jul; 18(7):951-4. PubMed ID: 21570299
[TBL] [Abstract][Full Text] [Related]
15. Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta.
Annunziata P; Giorgio A; De Santi L; Zipoli V; Portaccio E; Amato MP; Clerici R; Scarpini E; Moscato G; Iudice A; Vacca G; Orefice G; Morra VB; Maimone D
J Neurol Sci; 2006 May; 244(1-2):97-102. PubMed ID: 16473370
[TBL] [Abstract][Full Text] [Related]
16. Sulfatide isoform pattern in cerebrospinal fluid discriminates progressive MS from relapsing-remitting MS.
Novakova L; Singh AK; Axelsson M; Ståhlman M; Adiels M; Malmeström C; Zetterberg H; Borén J; Lycke J; Cardell SL; Blomqvist M
J Neurochem; 2018 Aug; 146(3):322-332. PubMed ID: 29676479
[TBL] [Abstract][Full Text] [Related]
17. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
Avsar T; Korkmaz D; Tütüncü M; Demirci NO; Saip S; Kamasak M; Siva A; Turanli ET
Mult Scler; 2012 Aug; 18(8):1081-91. PubMed ID: 22252467
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
Ahlbrecht J; Martino F; Pul R; Skripuletz T; Sühs KW; Schauerte C; Yildiz Ö; Trebst C; Tasto L; Thum S; Pfanne A; Roesler R; Lauda F; Hecker M; Zettl UK; Tumani H; Thum T; Stangel M
Mult Scler; 2016 Aug; 22(9):1202-14. PubMed ID: 26493127
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.
Khademi M; Kockum I; Andersson ML; Iacobaeus E; Brundin L; Sellebjerg F; Hillert J; Piehl F; Olsson T
Mult Scler; 2011 Mar; 17(3):335-43. PubMed ID: 21135023
[TBL] [Abstract][Full Text] [Related]
20. Neurofilament light as a prognostic marker in multiple sclerosis.
Salzer J; Svenningsson A; Sundström P
Mult Scler; 2010 Mar; 16(3):287-92. PubMed ID: 20086018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
